NCT01787162View on ClinicalTrials.gov

Screening for Pulmonary Vascular Changes in Patients With Chronic Myeloproliferative Diseases

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Myeloproliferative DisordersPulmonary Hypertension
Interventions
OTHER

Echocardiography, spiroergometry, cardiac catheterization

patients with CMPD will undergo echocardiography, spiroergometry, and right heart catheterization, if indicated

Trial Locations (1)

8036

Medical University of Graz, Pulmonology, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT01787162 - Screening for Pulmonary Vascular Changes in Patients With Chronic Myeloproliferative Diseases | Biotech Hunter | Biotech Hunter